HMB-45 immunohistochemical staining of sentinel lymph nodes: A specific method for enhancing detection of micrometastases in patients with melanoma

American Journal of Surgical Pathology

Volumn 24, Issue 8, 2000, Pages 1140-1146

  Baisden, Blaire L ^a   Askin, Frederic B ^a   Lange, Julie R ^a   Westra, William H ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

HMB 45; Immunohistochemistry; Lymph node nevi; Melanoma; Nevocellular aggregates; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PROGNOSIS; TUMOR DIAGNOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; AXILLA; BIOPSY; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; SKIN NEOPLASMS; STAINING AND LABELING;

EID: 0033867842     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200008000-00012     Document Type: Article

References (31)

1. Battyani Z, Xerri L, Hassoun J, Bonerandi JJ, Grob JJ. Tyrosinase gene expression in human tissues. Pigment Cell Res 1993;6:400-5.
2. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Handbook for Staging of Cancer, 4th ed. Philadelphia, PA: JB Lippincott, 1993.
3. Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 1997;81:57-63.
4. Blaheta HJ, Schittek B, Breuninger H, et al. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription -polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-8.
5. Blessing K, Sanders DS, Grant JJ. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998;32:139-46.
6. Carson KF, Wen DR, Li PX, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
7. Cochran AJ. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes [Editorial]. Am J Surg Pathol 1999;23: 1169-72.
8. Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer 1984; 34:159-63.
9. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathologic stage 1 malignant melanoma. An immunohistologic study. Am J Surg Pathol 1988;12:612-8.
10. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
11. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986;123:195-203.
12. Green R, Epstein JI. Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies. Am J Surg Pathol 1999;23:567-70.
13. Hatta N, Takata M, Takehara K, Ohara K. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients. J Clin Pathol 1998;51:597-601.
14. Jungbluth AA, Busam KJ, Gerald WL, et al. A103: an anti-melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998;22: 595-602.
15. Kaufmann O, Koch S, Burghardt J, Audring H, Dietel M. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 1998;11:740-6.
16. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996;20:1489-500.
17. Messina JL, Glass F, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23:686-90.
18. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
19. Reichert CM, Rosenberg SA, Weber BL, Costa J. Malignant melanoma: a search for occult lymph node metastases. Hum Pathol 1981;12:449-51.
20. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
21. Ridolfi RL, Rosen PP, Thaler H. Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer 1977;39:164-71.
22. Robert ME, Wen DR, Cochran AJ. Pathological evaluation of the regional lymph nodes in malignant melanoma. Semin Diagn Pathol 1993;10:102-15.
23. Rosai J. Cytokeratin expression in cauda equina paragangliomas [Letter]. Am J Surg Pathol 1999;23:491.
24. Ross MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
25. Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280: 1410-5.
26. Skelton HG, Maceira J, Smith KJ, McCarthy WF, Lupton GP, Graham JH. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol 1997;19:580-4.
27. Sun J, Morton THJ, Gown AM. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections. Am J Surg Pathol 1990;14:748-51.
28. Walts AE, Said JW, Shintaku IP. Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis. Am J Clin Pathol 1988;90:77-80.
29. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
30. Wood WS, Tron VA. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutan Pathol 1991;18:261-3.
31. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86: 617-27.